Diurnal rhythms in varicella vaccine effectiveness

JCI Insight. 2024 Sep 3;9(20):e184452. doi: 10.1172/jci.insight.184452.

Abstract

BACKGROUNDImmune processes are influenced by circadian rhythms. We evaluate the association between varicella vaccine administration time of day and vaccine effectiveness.METHODSA national cohort, children younger than 6 years, were enrolled between January 2002 and December 2023. We compared children vaccinated during morning (7:00-10:59), late morning to afternoon (11:00-15:59), or evening hours (16:00-19:59). A Cox proportional hazards regression model was used to adjust for ethnicity, sex, and comorbidities. The first varicella infection occurring at least 14 days after vaccination and a second dose administration were treated as terminal events.RESULTSOf 251,141 vaccinated children, 4,501 (1.8%) experienced breakthrough infections. Infection rates differed based on vaccination time, with the lowest rates associated with late morning to afternoon (11:00-15:59), HR 0.88, 95% CI 0.82-0.95, P < 0.001, and the highest rates with evening vaccination (16:00-19:59), HR 1.41, 95% CI 1.32-1.52, P < 0.001. Vaccination timing remained significant after adjustment for ethnicity, sex, and comorbidities. The association between immunization time and infection risk followed a sinusoidal pattern, consistent with a diurnal rhythm in vaccine effectiveness.CONCLUSIONWe report a significant association between the time of varicella vaccination and its clinical effectiveness. Similar association was observed with the COVID-19 vaccine, providing proof of concept consistent with a diurnal rhythm in vaccine effectiveness.

Keywords: Bacterial vaccines; Vaccines.

MeSH terms

  • Chickenpox Vaccine* / administration & dosage
  • Chickenpox Vaccine* / immunology
  • Chickenpox* / epidemiology
  • Chickenpox* / immunology
  • Chickenpox* / prevention & control
  • Child
  • Child, Preschool
  • Circadian Rhythm* / physiology
  • Cohort Studies
  • Female
  • Herpesvirus 3, Human / immunology
  • Humans
  • Immunization Schedule
  • Infant
  • Male
  • Proportional Hazards Models
  • Vaccination
  • Vaccine Efficacy*

Substances

  • Chickenpox Vaccine

Grants and funding

no funding was received for this study